Harrow Inc 's ability to collect accounts receivable sequentially worsen to 2.49, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Harrow Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 147 days, from 136 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 192 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1460, from overall ranking in the second quarter 2026 at 2028.

What is Receivable Turnover Ratio?
What is Harrow Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HROW Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	100.14 %	50.41 %	31.4 %	-4.71 %	44.42 %
Y / Y Revenue Change	40 %	11.26 %	-6.9 %	33.31 %	44.04 %
Receivable Turnover Ratio (TTM)	2.49	2.69	2.9	3.15	2.84
HROW's Total Ranking	# 1460	# 2028	# 923	# 1298	#
Accounts Receivable average collection period days	146	136	126	116	128
Seq. Receivable Change	31 %	17.08 %	-8.69 %	42.91 %	-1.55 %
Seq. Revenue Change	40.53 %	60.43 %	-50.56 %	25.61 %	11.67 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 49
Healthcare Sector	# 193
Overall Market	# 1460

Receivable Turnover Ratio Statistics
High	Average	Low
1.5	0.72	0
(Sep 30 2018)		(Mar 31 2014)

HROW Company Profile • Back to HROW Efficiency Comparisons • Compare HROW Receivables Turnover Ratio to its Competitors

Financial Statements
Harrow Inc 's Accounts Receivable	$ 155 Millions	Visit HROW's Balance sheet
Harrow Inc 's Sales TTM	$ 303 Millions	Visit HROW's Income Statement
Sources of HROW's Revenues		Visit HROW's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
HROW's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
HROW's Growth Rates	HROW's Roa	HROW's Inventory Turnover Ratio	HROW's Dividend Comparisons
HROW's Profitability Ratios	HROW's Roi	HROW's Asset Turnover Ratio	HROW's Dividend Growth
HROW's Valuation Ratios	HROW's Roe	HROW's Financial Strength Ratios	HROW's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Cryoport inc	5.32	$ 192.439 Millions	$ 36.205 Millions
Ptc Therapeutics inc	5.26	$ 1,155.554 Millions	$ 219.663 Millions
Carlsmed Inc	5.24	$ 71.084 Millions	$ 13.572 Millions
Repligen Corp	5.21	$ 805.610 Millions	$ 154.771 Millions
Biomerica Inc	5.17	$ 4.338 Millions	$ 0.838 Millions
Indivior Pharmaceuticals Inc	5.14	$ 1,376.000 Millions	$ 267.500 Millions
Ge Healthcare Technologies Inc	5.11	$ 19,878.000 Millions	$ 3,886.750 Millions
Sarepta Therapeutics Inc	5.08	$ 1,956.339 Millions	$ 384.763 Millions
Abbvie Inc	5.04	$ 66,014.000 Millions	$ 13,100.250 Millions
West Pharmaceutical Services Inc	5.00	$ 3,397.100 Millions	$ 680.050 Millions
Aquestive Therapeutics Inc	4.98	$ 48.837 Millions	$ 9.803 Millions
Pfizer Inc	4.98	$ 63,625.000 Millions	$ 12,785.250 Millions
Omniab Inc	4.88	$ 40.211 Millions	$ 8.233 Millions
Mirum Pharmaceuticals Inc	4.81	$ 670.778 Millions	$ 139.538 Millions
Bristol myers Squibb Company	4.77	$ 50,033.000 Millions	$ 10,493.500 Millions
Fulgent Genetics Inc	4.69	$ 329.873 Millions	$ 70.368 Millions
Bausch and Lomb Corp	4.68	$ 5,418.000 Millions	$ 1,158.500 Millions
Orthopediatrics Corp	4.61	$ 263.665 Millions	$ 57.191 Millions
Cryo cell International Inc	4.54	$ 31.127 Millions	$ 6.851 Millions
Waters Corporation	4.53	$ 5,611.362 Millions	$ 1,238.211 Millions
Orasure Technologies Inc	4.51	$ 116.113 Millions	$ 25.757 Millions
Neurocrine Biosciences Inc	4.49	$ 3,701.700 Millions	$ 824.800 Millions
Abeona Therapeutics Inc	4.47	$ 41.912 Millions	$ 9.369 Millions
Glaukos Corp	4.47	$ 578.355 Millions	$ 129.301 Millions
Bioventus Inc	4.46	$ 585.319 Millions	$ 131.366 Millions
Lantheus Holdings Inc	4.42	$ 1,561.890 Millions	$ 353.219 Millions
Eli Lilly And Company	4.41	$ 86,462.000 Millions	$ 19,590.250 Millions
Supernus Pharmaceuticals inc	4.35	$ 865.106 Millions	$ 199.089 Millions
Stoke Therapeutics Inc	4.32	$ 28.211 Millions	$ 6.527 Millions
Dexcom Inc	4.30	$ 5,104.900 Millions	$ 1,187.150 Millions

Date modified: 2026-11-10T10:00:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.